Dostarlimab, sold under the brand name Jemperli, is a mo...
wikipedia - 13 Jun 2022Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as a medication for the treatment of endometrial cancer.[4][5][7][8][9]
Dostarlimab
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as a medication for the treatment of endometrial cancer.[4][5][7][8][9]
Dostarlimab Earns FDA Priority Review in All Advanced Endometrial Cancers
Cancer Network - 24 Apr 2024Dostarlimab Earns FDA Priority Review in All Advanced Endometrial Cancers ...
FDA Accepts sBLA for Dostarlimab With Chemotherapy to Treat Endometrial Cancer
Pharmacy Times - 25 Apr 2024FDA Accepts sBLA for Dostarlimab With Chemotherapy to Treat Endometrial Cancer ...
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell ...
Nature.com - 11 Nov 2023Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell ... ...
NICE Recommends Dostarlimab Plus Chemo in MSI-High/dMMR Endometrial Cancer
OncLive - 05 Mar 2024NICE Recommends Dostarlimab Plus Chemo in MSI-High/dMMR Endometrial Cancer ...
Dostarlimab, Chemotherapy Combination is Cost Effective for Endometrial Cancer
DocWire News - 24 Apr 2024Dostarlimab, Chemotherapy Combination is Cost Effective for Endometrial Cancer ...
Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
ScienceDirect.com - 18 Oct 2023Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer ...
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer
Hospital Healthcare - 14 Mar 2024Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer ...
FDA Grants Priority Review for Expanded Indication of GSK's Jemperli
BioPharm International - 24 Apr 2024FDA Grants Priority Review for Expanded Indication of GSK's Jemperli ...
Jemperli (dostarlimab-gxly) to Treat Advanced Solid Tumours
Clinical Trials Arena - 29 Sep 2023Jemperli (dostarlimab-gxly) to Treat Advanced Solid Tumours ...
Dostarlimab/Chemo Yields “Unprecedented” OS in dMMR Endometrial Cancer
Cancer Network - 20 Mar 2024Dostarlimab/Chemo Yields “Unprecedented” OS in dMMR Endometrial Cancer ...
Dostarlimab, Chemotherapy Combo Is Cost Effective, Improves QOL for Endometrial Cancer Patients
DocWire News - 24 Apr 2024Dostarlimab, Chemotherapy Combo Is Cost Effective, Improves QOL for Endometrial Cancer Patients ...
Dostarlimab Plus Chemo Followed by Dostarlimab/Niraparib Improves PFS in Endometrial Cancer
OncLive - 20 Dec 2023Dostarlimab Plus Chemo Followed by Dostarlimab/Niraparib Improves PFS in Endometrial Cancer ...
Overall Survival in Patients With Primary Advanced or Recurrent Endometrial Cancer Treated With Dostarlimab Plus ...
OncLive - 29 Mar 2024Overall Survival in Patients With Primary Advanced or Recurrent Endometrial Cancer Treated With Dostarlimab Plus ... ...
Dostarlimab/Chemo Earns Positive CHMP Opinion in Advanced Endometrial Cancer
Cancer Network - 26 Oct 2023Dostarlimab/Chemo Earns Positive CHMP Opinion in Advanced Endometrial Cancer ...
Dostarlimab/Niraparib Improves PFS Outcomes in Advanced Endometrial Cancer
Cancer Network - 20 Dec 2023Dostarlimab/Niraparib Improves PFS Outcomes in Advanced Endometrial Cancer ...
Dostarlimab Plus Chemo Continues to Demonstrate Strong Clinical Efficacy in Advanced NSCLC
OncLive - 20 Oct 2023Dostarlimab Plus Chemo Continues to Demonstrate Strong Clinical Efficacy in Advanced NSCLC ...
CHMP Recommends Dostarlimab Plus Chemotherapy in dMMR/MSI-H Advanced/Recurrent Endometrial Cancer
OncLive - 16 Oct 2023CHMP Recommends Dostarlimab Plus Chemotherapy in dMMR/MSI-H Advanced/Recurrent Endometrial Cancer ...
Dostarlimab Combo Significantly Improves PFS in Advanced Endometrial Cancer
Cancer Network - 16 Nov 2023Dostarlimab Combo Significantly Improves PFS in Advanced Endometrial Cancer ...
Cobolimab/Dostarlimab Combination Shows Initial Efficacy and Safety Signals in Advanced NSCLC
OncLive - 10 Jan 2024Cobolimab/Dostarlimab Combination Shows Initial Efficacy and Safety Signals in Advanced NSCLC ...
What's New
- Candace Parker Announces Retirement After Historic 16-Year ...
- Two Russian journalists arrested over alleged work for Navalny group
- Arsenal shrug off derby pressure to send Man City title warning - ESPN
- Johnston scores OT goal for the ages for Stars in Game 3 against ...
- UFC star Conor McGregor becomes part owner of BKFC - ESPN
- Stanley Cup Playoffs Round 1, Game 4: Tampa Bay Lightning 6 ...
- Colin Jost tells Biden why his grandfather voted for Biden in 2020 ...
- Rafa's revenge! Rafael Nadal conquers Alex de Minaur in gritty ...
- Celtics 104-84 Heat (Apr 27, 2024) Game Recap - ESPN
- Bears draft Iowa punter Tory Taylor in fourth round
- Gaza protestors picket White House correspondents dinner, as ...
- Gaza protestors picket White House correspondents dinner, as ...